Glaxo vaccines for stock
Ended Awarded Last action
- Contract number
- HHSP284201700003G
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Obligated
- $133,372
Award facts
- Opportunity
-
- 65IB Solicitation number
- Contract value 100% obligated
- $133,372.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Administration, awarded a delivery order valued at $133,372.10 to GlaxoSmithKline, LLC for the provision of vaccines for stock. The contract was awarded on October 17, 2016, with an ultimate completion date of October 25, 2016, and operates under a Firm Fixed Price structure with no set-aside designation. The award is issued as a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), leveraging GlaxoSmithKline's established GSA contract vehicle to procure necessary pharmaceutical inventory.
GlaxoSmithKline, LLC, a foreign-owned pharmaceutical company headquartered in Durham, North Carolina, serves as the prime contractor and has established itself as a critical supplier of vaccines and pharmaceutical products to multiple federal agencies. The company's extensive federal contracting history demonstrates substantial involvement in national healthcare and immunization programs, with prior engagements across the Centers for Disease Control and Prevention, Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services. The company maintains significant Indefinite Delivery Contracts with ceiling values ranging up to $3.9 billion through the Federal Supply Schedule, positioning it as a key provider for government vaccine procurement and medical countermeasures across civilian and military healthcare systems.
Quick answers
Who was awarded contract HHSP284201700003G?
HHSP284201700003G was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Administration (Department of Health and Human Services) on October 17, 2016.
How much is contract HHSP284201700003G worth?
The government has obligated $133,372 on HHSP284201700003G.
Is contract HHSP284201700003G an order under another contract?
Yes. HHSP284201700003G is a delivery order under V797P2298D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract HHSP284201700003G competed?
The extent of competition for HHSP284201700003G was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award